Kembali ke Daftar Obat
Panduan penyiapan dan pemberian terapi medikasi
Panduan penyiapan dan pemberian terapi medikasi
Acyclovir Sodium
Risiko Phlebitis tinggi
Kejadian Sering (1/10 – 1/100 kejadian)
Harap perhatikan informasi penyiapan dan pemberian terapi dengan seksama.
Penyiapan
Sediaan
- 500mg, 1g
Rekomendasi Pengenceran (Konsentrasi)
- <7mg/ml
- 500mg dalam 100cc
- 1gr dalam 200cc
Pelarut
- D5%
- NaCl 0.9%
Pemberian
Rekomendasi Akses
IV
Rekomendasi Durasi Pemberian
drip (dengan pengenceran) dalam 1 jam
Stabilitas Obat Setelah Rekonstruksi
12 jam
Keamanan
pH
11
pH risiko tinggi (<4 / >9)
Osmolaritas Sesudah Pengenceran
500mg dalam 100ml D5% =289mOsm/kg
500mg dalam 100cc NS 0,9% =316 mOsm/kg
500mg dalam 100cc NS 0,9% =316 mOsm/kg
Osmolaritas rendah (<600)
Phlebitis
Ya
Sering (1/10 – 1/100 kejadian)
Harap perhatikan informasi penyiapan dan pemberian terapi dengan seksama.
Harap perhatikan informasi penyiapan dan pemberian terapi dengan seksama.
Inkompatibilitas
-
Dobutamine HCl
-
Dopamine HCl
-
Meropenem
-
Tramadol HCl
-
Caffeine Citrat
-
Pantoprazole Sodium Acetaminophen
-
Amifostine
-
Amsacrine
-
Aztreonam
-
Caspofungin Acetate
-
Cisatracurium Besylate
-
Cyclosporine
-
Diltiazem HCl
-
Fludarabine Phosphate
-
Foscarnet Sodium
-
Gemcitabine HCl
-
Gentamicin Sulfate
-
Granisetron HCl
-
Levofloxacin
-
Mepeidine HCl
-
Metoclopramide HCl
-
Morphine Sulfate
-
Ondansetron HCl
-
Piperacillin Sodium-Tazobactam Sodium
-
Quinupristin-Dalfopristin
-
Sargramostim
- Vinorelbine Tartrate
Klasifikasi GHS
Irritant
Manifestasi GHS
H315 (77.9%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (77.9%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H335 (71.6%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
H319 (77.9%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H335 (71.6%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
Sumber
- American Society of Health-System Pharmacists. 2021. ASHP® Injectable Drug Information: A Comprehensive Guide to Compatibility and Stability. 2021 Edition. eBook. American Society of Health-System Pharmacists. ISBN: 978-1-58528-690-4. doi.org/10.37573/9781585286850
- Manrique-Rodríguez, S., Heras-Hidalgo, I., Pernia-López, M.S. et al. Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety. Drugs R D 21, 39–64 (2021). https://doi.org/10.1007/s40268-020-00329-w
- https://pubchem.ncbi.nlm.nih.gov/compound/135398513